Medicinal chemistry – Page 24
-
-
BusinessOxford–AstraZeneca vaccine joins others with promising interim data
Cheap and fridge-stable candidate at least 60% and up to 90% effective at preventing disease
-
BusinessRegulatory panel unconvinced by Alzheimer’s antibody evidence
US FDA advisors vote against approving Biogen’s aducanumab on the basis of incomplete data analysis
-
WebinarEmerging strategies in covalent inhibition
Join us for a review of emerging strategies for the development of covalent inhibitors in drug discovery
-
BusinessModerna and Pfizer’s Covid-19 vaccines add more encouraging data
Pfizer–BioNTech reach safety threshold for emergency authorisation, while Moderna’s data peek suggests 95% efficacy
-
NewsScientists urge caution on use of lateral flow tests to screen for Covid-19
Preliminary review reveals devices perform poorly at identifying people infected with Sars-CoV-2
-
NewsTen chemistry innovations that Iupac says could change the world
How chemistry can tackle plastic recycling, climate change and Covid-19 among other challenges
-
ArticleAI and digital simulation for better medicines, made faster
Revolutionising pharma with next-generation technology to optimise and accelerate drug production processes
-
ArticleThe future is bright: protecting innovation during uncertain times
The annual Pharma Integrates event facilitates conversation and collaboration to drive future innovation and improve patient outcomes worldwide
-
ArticleFaster pharma: Catalytic innovation combats precious metals supply chain pain
Precious metal catalysts are key to pharma but subject to market forces that make reliance on supply a double-edged sword.
-
ReviewBiography of Resistance: The Epic Battle Between People and Pathogens
A book illustrating a global health threat more daunting than Covid-19: growing antibiotic resistance
-
OpinionThe ins and outs of vaccine trials
Derek Lowe lays out how the trials work, and why they get paused and restarted
-
OpinionA promising peep at Covid-19 vaccine efficacy
Pfizer–BioNTech’s will need to be one of many if we are to overcome the pandemic
-
BusinessEarly indications suggest Pfizer–BioNTech’s Covid-19 vaccine is effective
Company claims 90% efficacy at preventing disease, but experts call for data rather than press releases
-
ResearchNanoparticle can starve aggressive breast cancer cells of vital copper
A new engineered particle depletes copper from mitochondria, killing breast cancer cells in mice
-
NewsPandemic risks lost generation of junior scientists as charitable funding dries-up
Survey finds coronavirus, Brexit and lack of opportunities is forcing early career researchers backed by medical charities to consider alternative professions
-
PodcastGlycyrrhizic acid
A sweet treat with a deadly trick for Halloween – glycyrrhizic acid is found in black liquorice and sweeter than sucrose, but can cause heart problems and even prove fatal if consumed in excess
-
OpinionEthical challenge
Should researchers infect healthy people with Sars-CoV-2 to speed up vaccine testing?
-
FeatureEngineering a handshake for proteins
Once considered undruggable, chemists are beginning to grasp protein–protein interactions, according to Ian Le Guillou
-
ResearchPeptides self-assemble to support growth of artificial tumours
Cancer cells grown around bioengineered microfibres make an ideal model to test new chemotherapy drugs